555 related articles for article (PubMed ID: 2431092)
1. Molecular localization and polymorphism of HLA class II restriction determinants defined by Mycobacterium leprae-reactive helper T cell clones from leprosy patients.
Ottenhoff TH; Neuteboom S; Elferink DG; de Vries RR
J Exp Med; 1986 Dec; 164(6):1923-39. PubMed ID: 2431092
[TBL] [Abstract][Full Text] [Related]
2. HLA class II+ human keratinocytes present Mycobacterium leprae antigens to CD4+ Th1-like cells.
Mutis T; De Bueger M; Bakker A; Ottenhoff TH
Scand J Immunol; 1993 Jan; 37(1):43-51. PubMed ID: 8418472
[TBL] [Abstract][Full Text] [Related]
3. HLA and leprosy in the pre and postgenomic eras.
Geluk A; Ottenhoff TH
Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic and functional characterization of human suppressor T-cell clones: II. Activation by Mycobacterium leprae presented by HLA-DR molecules to alpha beta T-cell receptors.
Li SG; Elferink DG; de Vries RR
Hum Immunol; 1990 May; 28(1):11-26. PubMed ID: 1692823
[TBL] [Abstract][Full Text] [Related]
5. HLA-DR-restricted antigen-induced proliferation and cytotoxicity mediated by CD4+ T-cell clones from subjects vaccinated with killed M. leprae.
Mustafa AS; Qvigstad E
Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):1-11. PubMed ID: 2659694
[TBL] [Abstract][Full Text] [Related]
6. A systematic molecular analysis of the T cell-stimulating antigens from Mycobacterium leprae with T cell clones of leprosy patients. Identification of a novel M. leprae HSP 70 fragment by M. leprae-specific T cells.
Janson AA; Klatser PR; van der Zee R; Cornelisse YE; de Vries RR; Thole JE; Ottenhoff TH
J Immunol; 1991 Nov; 147(10):3530-7. PubMed ID: 1940353
[TBL] [Abstract][Full Text] [Related]
7. Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells.
Ottenhoff TH; Elferink DG; Klatser PR; de Vries RR
Nature; 1986 Jul 31-Aug 6; 322(6078):462-4. PubMed ID: 2426597
[TBL] [Abstract][Full Text] [Related]
8. HLA class-II-restricted Mycobacterium leprae-reactive T-cell clones from leprosy patients established with a minimal requirement for autologous mononuclear cells.
Haanen JB; Ottenhoff TH; Voordouw A; Elferink BG; Klatser PR; Spits H; De Vries RR
Scand J Immunol; 1986 Jan; 23(1):101-8. PubMed ID: 2422737
[TBL] [Abstract][Full Text] [Related]
9. Analysis of HLA-DR glycoproteins by DNA-mediated gene transfer. Definition of DR2 beta gene products and antigen presentation to T cell clones from leprosy patients.
Wilkinson D; de Vries RR; Madrigal JA; Lock CB; Morgenstern JP; Trowsdale J; Altmann DM
J Exp Med; 1988 Apr; 167(4):1442-58. PubMed ID: 3128633
[TBL] [Abstract][Full Text] [Related]
10. T cell responses to major membrane protein II (MMP II) of Mycobacterium leprae are restricted by HLA-DR molecules in patients with leprosy.
Ohyama H; Matsushita S; Nishimura F; Kato N; Hatano K; Takashiba S; Murayama Y
Vaccine; 2001 Nov; 20(3-4):475-82. PubMed ID: 11672912
[TBL] [Abstract][Full Text] [Related]
11. A Mycobacterium leprae-specific human T cell epitope cross-reactive with an HLA-DR2 peptide.
Anderson DC; van Schooten WC; Barry ME; Janson AA; Buchanan TM; de Vries RR
Science; 1988 Oct; 242(4876):259-61. PubMed ID: 2459778
[TBL] [Abstract][Full Text] [Related]
12. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
[TBL] [Abstract][Full Text] [Related]
13. Mycobacterium leprae-specific protein antigens defined by cloned human helper T cells.
Ottenhoff TH; Klatser PR; Ivanyi J; Elferink DG; de Wit MY; de Vries RR
Nature; 1986 Jan 2-8; 319(6048):66-8. PubMed ID: 2417123
[TBL] [Abstract][Full Text] [Related]
14. Cross-reactive epitopes and HLA-restriction elements in human T cell recognition of the Mycobacterium leprae 18-kD heat shock protein.
Mustafa AS; Lundin KE; Meloen RH; Oftung F
Clin Exp Immunol; 2000 Apr; 120(1):85-92. PubMed ID: 10759768
[TBL] [Abstract][Full Text] [Related]
15. HLA-DQ molecules and the control of Mycobacterium leprae-specific T cell nonresponsiveness in lepromatous leprosy patients.
Ottenhoff TH; Walford C; Nishimura Y; Reddy NB; Sasazuki T
Eur J Immunol; 1990 Oct; 20(10):2347-50. PubMed ID: 1700754
[TBL] [Abstract][Full Text] [Related]
16. [The genetic susceptibility to leprosy in humans].
Lagrange PH; Abel L
Acta Leprol; 1996; 10(1):11-27. PubMed ID: 8967289
[TBL] [Abstract][Full Text] [Related]
17. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
[TBL] [Abstract][Full Text] [Related]
18. HLA-DR polymorphism modulates the cytokine profile of Mycobacterium leprae HSP-reactive CD4+ T cells.
Mitra DK; Rajalingam R; Taneja V; Bhattacharyya BC; Mehra NK
Clin Immunol Immunopathol; 1997 Jan; 82(1):60-7. PubMed ID: 9000043
[TBL] [Abstract][Full Text] [Related]
19. On the mechanism of human T cell suppression.
Salgame P; Modlin R; Bloom BR
Int Immunol; 1989; 1(2):121-9. PubMed ID: 2535060
[TBL] [Abstract][Full Text] [Related]
20. Clonal analysis of HLA-DR and -DQ associated determinants: their contribution to Dw specificities.
Reinsmoen NL; Bach FH
Hum Immunol; 1986 Aug; 16(4):329-46. PubMed ID: 2428780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
